Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice
Carlos Bernal‐Mizrachi(Washington University in St. Louis), Clay F. Semenkovich(Washington University in St. Louis), Sherry Weng(Cardiovascular Research Center), Robert P. Mecham(University of Missouri–St. Louis), Brian N. Finck(Washington University in St. Louis), Feng Chu(Cardiovascular Research Center), Teresa C. Leone(Cardiovascular Institute of the South), Russell H. Knutsen(Washington University in St. Louis), Trey Coleman(Cardiovascular Research Center), Daniel P. Kelly(Washington University in St. Louis)
Cited by 211
Related Papers
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
|Journal of Clinical Investigation|2006|1.4k
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
|Journal of Clinical Investigation|2000|1.3k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|942
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
|Proceedings of the National Academy of Sciences|1999|940
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|879